Jeffrey B. Bove Counsel | Wilmington, DE
Jeff Bove is a patent and commercial litigation attorney who represents clients primarily in the United States District Court for the District of Delaware and the United States Court of Appeals for the Federal Circuit. He provides local counsel services for out of state clients in the District of Delaware, having appeared in over 140 cases. He frequently represents branded pharmaceutical companies seeking to protect key products and patents in ANDA cases.
Jeff’s practice includes the representation of clients in the areas of patent litigation, complex commercial litigation, technology licensing, patent misuse evaluations including serving as Delaware counsel in numerous cases. With over 40 years of litigation experience, Jeff has also served as lead counsel in numerous cases involving a variety of subjects. He argued successfully the Bayer v. Housey appeal for Bayer Corporation at the Federal Circuit, an important case of first impression involving the scope of 35 U.S.C. § 271(g). As co-counsel, Jeff represented Pfizer in Pfizer v. Ranbaxy, in which Pfizer’s basic patent covering Lipitor® was upheld. For a description of Jeff’s experience, see the summary below of some of the patent cases which he has litigated.
Jeff was the Managing Partner and Practice Leader of the Intellectual Property Group of Connolly Bove Lodge & Hutz LLP. He served on the Board of Governors of the Federal Circuit Bar Association from 2012-2018 and was specially recognized by the Association at its 2018 Bench and Bar Conference for this service. He was appointed Chair of the Legislative Committee and Vice Chair of the Judicial Appointments Committee of the Federal Circuit Bar Association for 2018. He is a Fellow of the American Bar Foundation and has been named in Best Lawyers® for Antitrust Law for each of 2011-2022. Jeff is also a co-author of the ABA publication, “ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators,” Chapter 3, Notice and Pre-Filing Considerations, and Chapter 18, Trial (1st ed. 2012; 2d ed. 2016).